NSEAnalysts/Institutional Investor Meet/Con. Call Updates29 Sept 2026 · 29 Sept 2026, 07:40 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Stallion India Fluorochemicals Limited · STALLION
✦ AI SummaryMgmt Change
Stallion India Fluorochemicals Limited has informed the Exchange about the schedule of an analyst/investor meeting to be held on October 2, 2026, with two sessions at 3:00 PM and 4:30 PM IST.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Stallion India Fluorochemicals Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
STALLION_29092026194012_Intimation_Analyst_Meeting-02_10_2026-Signed.pdf
View document text
Date: 29th September, 2026
To, To,
National Stock Exchange of India Limited (“NSE”), BSE Limited (“BSE”),
The Listing Department Corporate Relationship Department,
Exchange Plaza, 5th Floor, 2nd Floor, New Trading Ring,
Plot No. C/1, G Block, Bandra-Kurla Complex Bandra P.J. Towers, Dalal Street,
(East), Mumbai – 400 051. Mumbai – 400 001.
NSE Symbol: STALLION BSE Scrip Code: 544342
ISIN: INE0RYC01010 ISIN: INE0RYC01010
Dear Sir/ Madam,
Sub: Intimation of Schedule of Analyst/Investor Meeting pursuant to Regulation 30 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015.
Pursuant to the Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
as amended, (“SEBI Listing Regulations”), read with Part A of Schedule III to the SEBI Listing Regulations, we wish
to inform you that the management of the Company will meet with Analyst/Investors on Friday, 02nd October, 2026.
The details of the same are given below:
Sr. No. Name Mode Time (IST)
1 New Horizon In-person Meeting 3:00 PM
2 Elios Financial Services Virtual Meeting 4:30 PM
Note: The above schedule is subject to change due to exigencies on the part of the Company or the concerned
analysts/investors. Any changes in the schedule will be intimated to the Stock Exchanges, wherever required.
No unpublished price sensitive information (UPSI) will be discussed.
We request you to kindly take the same on records.
Yours Faithfully,
For Stallion India Fluorochemicals Limited
Govind Rao
Company Secretary & Compliance Officer
Membership No.: A47094